12:00 AM
 | 
Feb 21, 2011
 |  BC Week In Review  |  Company News  |  Deals

Sygnis Pharma deal

Sygnis received exclusive rights from an undisclosed party to a European patent covering the use of G-CSF for...

Read the full 68 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >